Stoke Therapeutics, Inc. (STOK)
31.68
-0.14
(-0.42%)
USD |
NASDAQ |
Dec 31, 16:00
31.70
+0.02
(+0.05%)
After-Hours: 20:00
Stoke Therapeutics Market Cap: 1.810B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.83B |
| Janux Therapeutics, Inc. | 829.74M |
| Insmed, Inc. | 37.13B |
| Aldeyra Therapeutics, Inc. | 311.34M |
| Mirum Pharmaceuticals, Inc. | 4.061B |
Market Cap Related Metrics
| PE Ratio | 48.01 |
| PS Ratio | 8.991 |
| Price to Book Value | 5.874 |
| Price to Free Cash Flow | 35.30 |
| Price | 31.68 |
| Earnings Yield | 2.08% |
| Operating PE Ratio | 67.98 |
| Normalized PE Ratio | 48.01 |